ReviewPregnancy (Hoboken, N.J.)2025
Interpregnancy management for women with sickle cell disease: A systematic review.
Review in Pregnancy (Hoboken, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- New WHO recommendations on the management of sickle-cell disease in pregnancy.Pregnancy (Hoboken, N.J.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Sickle cell disease (SCD) is a haemoglobin disorder associated with painful sickle cell crises and haemolytic anaemia. SCD affects millions of individuals worldwide, with a significant impact on pregnant women and children. However, there is currently a lack of information regarding appropriate care postpartum and between pregnancies that could potentially reduce the risk of morbidity and mortality. We aimed to evaluate the effectiveness and safety of medication and transfusion management for women with SCD during the interpregnancy period. Methods: Types of eligible study include randomized controlled trials (RCTs), cluster-RCTs, quasi-experimental studies (or non-randomized clinical trials) and prospective and retrospective cohort studies. We conducted a systematic search for relevant published articles from PubMed, CENTAL, Scopus, CINAHL and Embase databases from inception to 6 December 2023, with no limitations. The study protocol was published in PROSPERO. Results: A total of 7888 citations were identified in the search (following deduplication). However, none of the studies met the inclusion criteria after the selection process (title and abstract screening and full-text evaluation). Conclusions: There is no direct evidence to indicate the effectiveness and safety of medication and transfusion management for women with SCD during the interpregnancy period. PROSPEERO Registration: CRD42023460798.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.